Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Crohn’s & Colitis Foundation’s IBD Ventures Invests $2.4 Million in Developing Novel Products to Address Unmet Needs of IBD Patients

Since 2017, IBD Ventures Has Invested Over $9 Million In R&D Funding to Portfolio Companies

March 21, 2023

Early Life Stress in Mice Impairs Gut Immune Regulation and Leads to Worsened Future Colonic Inflammation

New York, NY, March 14, 2023 – Early life stress (ELS) in mice can disrupt the gut immune response, leading to longer-lasting intestinal inflammation and a worsened future disease state than control mice not exposed to ELS, according to a new study published in Inflammatory B

March 15, 2023

Crohn’s & Colitis Foundation and Nestlé Health Science launch Gut-Friendly Recipes, a free new online recipe finder tool with 500+ recipes

The Crohn’s & Colitis Foundation and Nestlé Health Science today announced the launch of Gut Friendly Recipes, a free new online recipe finder tool with more than 500 easy recipes for gut-friendly and nutritious meals. The easy-to-navigate recipe finder can be found at www.gutfriendlyrecipes.org. Gut Friendly Recipes offers a broad selection of delicious recipes for Inflammatory Bowel Disease (IBD) patients, people with chronic digestive issues, and for anyone seeking nutritious and gut-friendly meals.

January 31, 2023

New National Survey Shows Lack of Public Restrooms is Widespread Public Health Issue

NEW YORK, NY, November 17, 2022 — A new survey of U.S.

November 17, 2022

Crohn’s & Colitis Foundation announces Sharon Lungrin as new member of senior leadership team

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today the hire of Shar

July 18, 2022

Pomegranate extract dietary supplement lowers Inflammation and reduces disease severity in a pre-clinical model of colitis

NEW YORK, NY – Dietary supplementation of pomegranate extract decreased disease severity and lowered inflammation in mice with colitis, according to a new study published in Molecular Nutrition and Food Research and

February 25, 2022

First-of-its-kind technology provides individualized, actionable insights on dose and interval for infliximab

Prometheus Laboratories recently announced the launch of PredictrPK IFX, which uses a machine learning algorithm to combine patient weight, current dose and interval, measured serum IFX, measured antibodies-to-infliximab and albumin levels to predict optimal, individualized infliximab dosing.

February 23, 2022

We Can’t Wait App featured in Fast Company

CEO Michael Osso recently spoke with Fast Company about how the We Can’t Wait app is connecting users to over 45,000 public restrooms across the country.

February 15, 2022

We Can’t Wait: New app helps inflammatory bowel disease patients find available restrooms nearby

NEW YORK, NY — The Crohn’s & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving patient quality of life, today launched the We Can’t Wait app, which provides an interactive map that allows users to find a restroom near them

February 8, 2022

11 Health & Technologies receives funding from Crohn’s & Colitis Foundation IBD Ventures to further develop world’s first digital ostomy wearable, the Remote Output Monitor

ORANGE COUNTY, CA – 11 Health & Technologies Inc., a medical technology company with a proven technology to reduce complications in ostomy patients, announced today that it has received funding from the Crohn’s & Colitis Foundation’s

January 10, 2022